Category

Smartkarma Newswire

HM Sampoerna (HMSP) Earnings: 1H Net Income Drops 12% YoY to 3.32T Rupiah Amid Revenue Growth

By | Earnings Alerts
  • HM Sampoerna‘s net income for the first half of 2024 is 3.32 trillion rupiah.
  • This net income represents a 12% decrease compared to the same period last year.
  • Total revenue for the first half of 2024 is 57.82 trillion rupiah, showing a 3% increase year-over-year.
  • Earnings per share (EPS) are 29 rupiah, down from 32 rupiah in the previous year.
  • Analyst recommendations include 14 buys, 3 holds, and 3 sells.
  • All comparisons are based on values reported in the company’s original disclosures.

A look at HM Sampoerna Smart Scores

FactorScoreMagnitude
Value2
Dividend5
Growth3
Resilience5
Momentum3
OVERALL SMART SCORE3.6

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

PT Hanjaya Mandala Sampoerna Tbk, a company known for manufacturing clove-blended cigarettes, seems to have a positive long-term outlook based on Smartkarma Smart Scores. With a strong score of 5 in Dividend and Resilience, Sampoerna is recognized for its ability to provide consistent dividend payouts and withstand market challenges effectively. Additionally, a Growth score of 3 indicates moderate potential for expansion, while Momentum at 3 suggests a stable trajectory in the near future.

The company’s overall outlook, as indicated by the combination of these scores, appears promising. Sampoerna’s focus on dividends and resilience, coupled with opportunities for growth and a steady momentum, positions it well for the future. As a manufacturer of clove-blended cigarettes with a presence in both domestic and international markets, Sampoerna’s diversified operations and strong financial standing contribute to its positive Smartkarma Smart Scores.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Rheinmetall AG (RHM) Earnings: Preliminary 2Q Profit Surges to €271M, Beating Estimates

By | Earnings Alerts





Rheinmetall Quarterly Highlights

  • Preliminary operating profit for Q2 stands at approximately EU271 million, exceeding the estimate of EU213.9 million.
  • Preliminary sales for Q2 are reported at about EU2.23 billion.
  • Rheinmetall maintains its full-year sales forecast at around EU10 billion, as estimated at EU9.92 billion.
  • The operating margin forecast for the year remains between 14% and 15%, aligning with previous expectations.
  • Strong financial performance is driven by early sales recognition in the Weapon and Munitions division and increased sales from Rheinmetall Expal Munitions in the first half of the year.
  • Management stands by its sales and earnings forecast for the entire year 2024.
  • The full financial figures for the second quarter will be published on August 8.
  • Shares of Rheinmetall saw a 2.8% increase, trading at EU507.40 with 47,377 shares exchanged.
  • Market sentiment includes 16 buy ratings, 4 hold ratings, and no sell ratings.



A look at Rheinmetall AG Smart Scores

FactorScoreMagnitude
Value2
Dividend2
Growth5
Resilience3
Momentum3
OVERALL SMART SCORE3.0

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores for Rheinmetall AG, the company’s long-term outlook appears positive. With a strong Growth score of 5, Rheinmetall AG is indicating potential for significant expansion and development in the future. This is complemented by respectable scores in Resilience and Momentum, suggesting the company is well-positioned to weather challenges and maintain its operational pace.

Although the Value and Dividend scores are moderate at 2, Rheinmetall AG‘s diverse portfolio in automotive, electronics, defense, and engineering sectors provides a solid foundation for sustained performance. The Company’s production of automotive components and aftermarket services further solidifies its position in the market, enhancing its potential for future growth.

Summary:
Rheinmetall AG is an automotive, electronics, defense, and engineering group that specializes in producing a wide range of automotive pumps, components, pistons, bearings, and aluminum engine blocks. Additionally, the company offers aftermarket services catering to engine repair shops.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Samsung Biologics (207940) Earnings: 2Q Operating Profit Surges 71%, Beating Estimates

By | Earnings Alerts
  • Operating Profit: Samsung Biologics’ operating profit for Q2 2024 is 434.51 billion won, a 71% increase year-over-year.
  • Estimates Surpassed: The operating profit exceeds the market estimate of 308.83 billion won.
  • Net Profit: The company reported a net profit of 317.99 billion won, up 72% from the previous year.
  • Net Profit Estimate: The net profit also surpasses the forecast of 230.29 billion won.
  • Sales Growth: Samsung Biologics recorded sales of 1.16 trillion won, marking a 34% year-over-year increase.
  • Sales Estimate: This sales figure is higher than the estimated 1.01 trillion won.
  • Analyst Ratings: Out of analyst recommendations, there are 30 buys, 1 hold, and 1 sell.

Samsung Biologics on Smartkarma

Analyst coverage on Samsung Biologics by Tina Banerjee on Smartkarma indicates a positive trend for the company. In one report, titled “Samsung Biologics (207940 KS): Gaining Momentum on New Approval and Contract Wins; Hold Shares,” Samsung Biologics secured a significant $1.1B contract, contributing to 40% of the expected 2023 revenue. Additionally, FDA approval for the Stelara biosimilar Pyzchiva further adds to the company’s achievements.

In another insightful report, “Samsung Biologics (207940 KS): Mixed 1Q24 Result; Order Book Swells; New Drug Approval in Europe,” Samsung Biologics surpassed sales and net profit estimates for the first quarter of 2024. Despite a minor operating profit miss, the company’s strong order book of over $12B and approval for a new biosimilar in Europe paint a promising future for Samsung Biologics.


A look at Samsung Biologics Smart Scores

FactorScoreMagnitude
Value2
Dividend1
Growth5
Resilience4
Momentum4
OVERALL SMART SCORE3.2

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on Smartkarma Smart Scores, Samsung Biologics has a strong long-term outlook. With a high Growth score of 5, the company is set to expand and develop rapidly in the future. Additionally, Samsung Biologics scores well on Resilience and Momentum, with scores of 4, indicating its ability to withstand market fluctuations and its current positive market trend. However, the company’s Value score is lower at 2, suggesting that it may be slightly overvalued. The Dividend score of 1 indicates that Samsung Biologics does not heavily focus on distributing dividends to its shareholders.

Samsung Biologics Co., Ltd. is a company that focuses on the manufacturing of bio-healthcare products. They are involved in the development, refinement, and distribution of biopharmaceutical products. With strong scores in Growth, Resilience, and Momentum, Samsung Biologics shows promise for future growth and resilience in the market. Investors may need to consider the company’s slightly lower Value score and minimal focus on dividends when making investment decisions regarding Samsung Biologics.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Bajaj Finserv (BJFIN) Earnings: Q1 Net Income Rises to 21.3B Rupees, Revenue Up by 35%

By | Earnings Alerts
  • Net Income Growth: Bajaj Finserv reported a net income of 21.3 billion rupees for the first quarter, marking a 9.8% increase compared to the same period last year, which was 19.4 billion rupees.
  • Revenue Surge: The company’s revenue jumped by 35% year-over-year, reaching 314.8 billion rupees.
  • Total Costs: Total costs for the quarter rose to 255.1 billion rupees, representing a 40% increase compared to the previous year.
  • Stock Performance: Despite the positive financial results, Bajaj Finserv shares fell by 2%, closing at 1,586 rupees on a trading volume of 1.46 million shares.
  • Analyst Ratings: The company currently has 8 buy ratings, 1 hold rating, and 2 sell ratings from analysts.

A look at Bajaj Finserv Smart Scores

FactorScoreMagnitude
Value3
Dividend2
Growth3
Resilience2
Momentum2
OVERALL SMART SCORE2.4

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Analyzing the Smartkarma Smart Scores for Bajaj Finserv, the company shows a moderate to positive long-term outlook. With a solid Value score of 3, indicating a fair valuation, and a Growth score of 3, signaling potential growth opportunities, Bajaj Finserv appears to be positioned for steady development in the future. However, the company’s lower scores in Dividend, Resilience, and Momentum may suggest areas that require attention to enhance overall performance.

Bajaj Finserv Ltd. is a multifaceted company operating in life insurance, general insurance, consumer finance, and renewable energy sectors in India. With plans to broaden its range of financial products and services, the company aims to strengthen its market presence and develop new revenue streams. By leveraging its expertise across various financial segments, Bajaj Finserv seeks to capitalize on emerging opportunities and solidify its position in the competitive Indian financial landscape.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Informa PLC (INF) Earnings: FY Revenue and Profit Guidance Surpass Expectations

By | Earnings Alerts





Informa Financial Highlights

  • Revenue Guidance: Informa expects full-year revenue above GBP 3.45 billion to GBP 3.50 billion, previously seen at the high end of this range. Current estimate is GBP 3.48 billion.
  • Profit Guidance: Adjusted operating profit is estimated above GBP 950 million to GBP 970 million, previously seen at the high end of this range. Current estimate is GBP 972.6 million.
  • First Half Results:
    • Adjusted operating profit: GBP 466.9 million, up 13% year-on-year, estimated at GBP 457.6 million.
    • Adjusted pretax profit: GBP 441.2 million, up 6% year-on-year, estimated at GBP 432.5 million.
    • Statutory pretax profit: GBP 237.4 million, down 25% year-on-year, estimated at GBP 267 million.
    • Revenue: GBP 1.70 billion, up 11% year-on-year, estimated at GBP 1.69 billion.
  • Segment Results:
    • Informa Markets revenue: GBP 838.3 million, estimate GBP 857.1 million.
    • Informa Connect revenue: GBP 328.3 million, estimate GBP 326.4 million.
    • Informa Tech revenue: GBP 227.6 million, estimate GBP 210.5 million.
    • Taylor & Francis revenue: GBP 301.1 million, estimate GBP 297.3 million.
  • Dividend: Interim dividend per share is 6.4 pence, up from 5.8 pence year-on-year.
  • Comments:
    • Informa anticipates adjusted operating profit to exceed the previous guidance range, potentially reaching up to GBP 1 billion.
    • Strong performance across all business segments and good visibility forward, bolstered by AI partnerships, have led to higher expectations for the full year.
    • Double-digit underlying revenue growth expected for B2B Markets and Academic Markets.
  • Analyst Recommendations: 10 buys, 2 holds, 0 sells.



A look at Informa PLC Smart Scores

FactorScoreMagnitude
Value3
Dividend3
Growth5
Resilience3
Momentum4
OVERALL SMART SCORE3.6

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Informa PLC, a global provider of business information, is positioned for long-term growth based on its Smartkarma Smart Scores. With a strong Growth score of 5, the company is expected to expand steadily in the future. Supported by a Momentum score of 4, Informa PLC shows promising trends in the market that could fuel its performance.

Furthermore, while the Value, Dividend, and Resilience scores sit at moderate levels, indicating stability, the overall outlook for Informa PLC appears positive. With a diverse range of market segments served, including finance, insurance, and biomedical industries, Informa’s broad information offerings position it well for sustained success in the long run.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Reckitt Benckiser Group (RKT) Earnings: Lowered FY Sales Forecast and Solid Interim Dividend

By | Earnings Alerts
  • Reckitt revises its forecast for full-year like-for-like sales growth to 1% to 3%, down from the previous forecast of 2% to 4%.
  • Interim dividend per share announced at 80.4p, surpassing the estimated 74.1p.
  • First half net revenue stands at GBP7.17 billion, slightly below the estimate of GBP7.18 billion.
  • First half like-for-like sales growth reported at 0.8%, below the estimated 1.11%.
  • Volume decline of 1.3%, compared to the estimated decline of 0.85%.
  • Price/mix increase of 2.1%, slightly above the estimated 1.94%.
  • Adjusted operating profit for the first half recorded at GBP1.68 billion, higher than the estimated GBP1.64 billion.
  • Hygiene segment adjusted operating profit reaches GBP654 million, exceeding the estimate of GBP634.7 million.
  • Health segment adjusted operating profit at GBP819 million, higher than the estimated GBP805.1 million.
  • Nutrition segment adjusted operating profit at GBP210 million, surpassing the estimate of GBP201.6 million.
  • Overall adjusted operating margin reported at 23.5%, compared to the estimated 22.9%.
  • Hygiene adjusted operating profit margin stands at 21.4%, above the estimated 20.7%.
  • Health adjusted operating profit margin at 27.8%, slightly higher than the estimated 27.6%.
  • Nutrition adjusted operating profit margin at 18%, higher than the estimated 17%.
  • Second quarter like-for-like sales at 0%, below the estimated 0.59%.
  • Second quarter Health like-for-like sales growth of 1.7%, short of the estimated 2.32%.
  • Second quarter Hygiene like-for-like sales growth at 1.9%, versus the estimated 2.54%.
  • Nutrition like-for-like sales in the second quarter declined by 8.1%, better than the estimated decline of 9.01%.
  • North America like-for-like sales decline by 3.6%, in line with the estimated decline of 3.67%.
  • Europe/ANZ like-for-like sales growth at 2.2%, lower than the estimated 3.36%.
  • Developing markets like-for-like sales growth at 1.4%, below the estimated 3.33%.
  • Second quarter volume decline of 2.2%, versus the estimated decline of 1.39%.
  • Price/mix increase of 2.2% in the second quarter, above the estimated 1.96%.
  • Second quarter net revenue reported at GBP3.43 billion, slightly below the estimate of GBP3.44 billion.
  • Health revenue in the second quarter matches the estimate at GBP1.40 billion.
  • Hygiene revenue in the second quarter at GBP1.45 billion, below the estimated GBP1.47 billion.
  • Nutrition revenue in the second quarter at GBP575 million, exceeding the estimated GBP559.7 million.
  • Reckitt expects adjusted operating profit to grow faster than net revenue for the full year.
  • Company anticipates acceleration in revenue growth in the second half of the year.
  • Plans to increase dividends and initiate a new share buyback program of Β£1 billion over the next 12 months.
  • Like-for-like revenue growth revision attributed to temporary supply disruption caused by the July 9 tornado in Mount Vernon, Indiana, affecting the Nutrition business.
  • Announcement of a strategic update to refine their portfolio and simplify the organization.

A look at Reckitt Benckiser Group Smart Scores

FactorScoreMagnitude
Value2
Dividend4
Growth5
Resilience2
Momentum2
OVERALL SMART SCORE3.0

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Reckitt Benckiser Group PLC, a global manufacturer and distributor of household, toiletry, health, and food products, is positioned for long-term success based on its Smartkarma Smart Scores. With a high Growth score of 5, the company shows potential for continuous expansion and development in various markets. Additionally, a strong Dividend score of 4 indicates solid returns for investors seeking income from their investment in the company.

While Reckitt Benckiser Group scores lower in Value, Resilience, and Momentum, its strong Growth and Dividend scores suggest a promising outlook for the company’s future performance. Investors may find the company attractive for its growth prospects and dividend payments amidst its diverse product portfolio spanning fabric treatments, disinfectants, personal care, food, and more.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

OBIC Co Ltd (4684) Earnings: 1Q Operating Income Misses Estimates Despite Strong Net Income Growth

By | Earnings Alerts
“`html

  • Obic reported a 1Q operating income of 18.65 billion yen, which missed the estimate of 19.16 billion yen.
  • Net income for the quarter was 16.78 billion yen, surpassing the estimate of 15.39 billion yen, showing a 14% increase year-over-year (y/y).
  • Net sales reached 28.78 billion yen, falling short of the 29.63 billion yen estimate, but still up 6.2% y/y.
  • For the 2025 fiscal year, the company forecasts operating income of 78.00 billion yen, slightly below the 79.02 billion yen estimate.
  • Obic also maintains its forecast for net income at 63.00 billion yen, compared to an estimate of 63.35 billion yen.
  • The company projects net sales of 122.80 billion yen, just under the estimate of 123.03 billion yen.
  • Analyst ratings on Obic include 5 buys, 7 holds, and 1 sell.

“`


A look at OBIC Co Ltd Smart Scores

FactorScoreMagnitude
Value2
Dividend2
Growth4
Resilience4
Momentum3
OVERALL SMART SCORE3.0

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

OBIC Co Ltd stands at a promising position for long-term growth, based on the Smartkarma Smart Scores analysis. With a strong focus on Growth and Resilience, scoring 4 in both categories, the company is well-positioned to capitalize on future opportunities and navigate challenges effectively.

Furthermore, OBIC Co Ltd‘s moderate scores in Value, Dividend, and Momentum indicate a balanced approach towards financial stability, shareholder returns, and market dynamics. This diversified assessment suggests a well-rounded performance outlook for the company in the coming years.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Porsche (P911) Earnings: 1H Operating Return on Sales Surpasses Estimates Despite Supply Shortages

By | Earnings Alerts
  • Porsche’s operating return on sales for the first half of 2024 was 15.7%, which is above the estimate of 14.9% but lower than last year’s 18.9%.
  • Revenue for the first half of 2024 reached EUR 19.46 billion, a 4.7% decrease from last year, but it exceeded the estimate of EUR 19.19 billion.
  • Operating profit for the same period was EUR 3.06 billion, marking a 21% decline year-over-year, yet it surpassed the estimate of EUR 2.89 billion.
  • Automotive net cash flow was EUR 1.12 billion, a 50% drop from the previous year; however, it still came in above the estimate of EUR 1.04 billion.
  • On July 23, Porsche AG adjusted its 2024 forecast due to significant supply shortages of special aluminium alloys from various suppliers.
  • Despite immediate countermeasures, the supply shortage is expected to result in production impairments that will not be fully compensated throughout the year.

Dr Ing hc F Porsche on Smartkarma



Analyst Coverage of <a href="https://smartkarma.com/entities/dr-ing-hc-f-porsche-ag">Dr Ing hc F Porsche </a>on Smartkarma

Analysts on Smartkarma, such as Nicolai Tangen from ‘In Good Company,’ have closely examined Dr Ing hc F Porsche, delving into aspects like leadership, iconic cars, and Chinese competition. Tangen’s bullish perspective highlights Porsche’s strong brand association with motorsport success, emphasizing drivability, innovation, and top performance both on and off the racetrack. The iconic nature of the number 911, symbolizing Porsche’s first edition introduced in 1963, further underscores the brand’s heritage and focus on delivering sporty, exclusive driving experiences.


A look at Dr Ing hc F Porsche Smart Scores

FactorScoreMagnitude
Value2
Dividend4
Growth3
Resilience4
Momentum2
OVERALL SMART SCORE3.0

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Dr. Ing hc F Porsche, known for manufacturing passenger vehicles including sports cars and SUVs, has a mixed outlook based on Smartkarma Smart Scores. With a Value score of 2, the company may not be considered undervalued in the market. However, its Dividend score of 4 suggests a strong potential for providing dividends to investors. In terms of Growth, the company has a score of 3, indicating moderate growth prospects. Dr Ing hc F Porsche’s Resilience score of 4 implies a resilience against market volatility, while its Momentum score of 2 reflects a slower pace of upward movement in the market. Overall, despite some positive indicators such as dividends and resilience, the company may face challenges in terms of value and momentum.

Dr. Ing hc F Porsche Aktiengesellschaft caters to a global customer base with its range of luxury vehicles and financial services. While the company shows strength in providing dividends and displaying resilience, there are areas such as value and momentum that may warrant closer attention. Investors considering Dr Ing hc F Porsche should weigh these factors carefully to make informed decisions about the long-term potential of the company in the automotive industry.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Reckitt Benckiser Group (RKT) Earnings: FY Sales Forecast Cut Amid Strong Operating Profit and Dividend Increase

By | Earnings Alerts
  • FY Sales Forecast Revision: Reckitt now expects like-for-like sales growth of 1% to 3%, down from the previous 2% to 4%.
  • Interim Dividend: Interim dividend per share is 80.4p, higher than the estimated 74.1p.
  • Net Revenue: Net revenue for the first half is GBP 7.17 billion, nearly matching the estimate of GBP 7.18 billion.
  • Like-for-Like Sales: 0.8%, slightly below the estimate of 1.11%.
  • Volume Performance: Volume decreased by 1.3%, more than the estimated decrease of 0.85%.
  • Price/Mix Improvement: Increased by 2.1%, better than the estimated 1.94%.
  • Adjusted Operating Profit: GBP 1.68 billion, exceeding the estimate of GBP 1.64 billion.
  • Segment Performance:
    • Hygiene: Adjusted operating profit GBP 654 million, above the estimate of GBP 634.7 million. Operating profit margin 21.4%, higher than the estimated 20.7%.
    • Health: Adjusted operating profit GBP 819 million, higher than the estimate of GBP 805.1 million. Operating profit margin 27.8%, above the estimated 27.6%.
    • Nutrition: Adjusted operating profit GBP 210 million, surpassing the estimate of GBP 201.6 million. Operating profit margin 18%, better than the estimated 17%.
  • Second Quarter Sales: Like-for-like sales were flat at 0%, not meeting the estimate of 0.59%.
  • Health Segment: Sales grew 1.7%, under the estimate of 2.32%.
  • Hygiene Segment: Sales grew 1.9%, below the estimate of 2.54%.
  • Nutrition Segment: Sales declined 8.1%, better than the estimated 9.01% decrease.
  • Regional Performance:
    • North America: Sales declined 3.6%, aligning closely with the estimate of a 3.67% decrease.
    • Europe/ANZ: Sales grew 2.2%, falling short of the estimated 3.36% growth.
    • Developing Markets: Sales grew 1.4%, below the estimate of 3.33% growth.
  • Volume and Price/Mix in Q2:
    • Volume: Decreased by 2.2%, more than the estimated decrease of 1.39%.
    • Price/Mix: Increased by 2.2%, exceeding the estimate of 1.96%.
  • Q2 Net Revenue: GBP 3.43 billion, close to the estimate of GBP 3.44 billion.
  • Segment Revenues in Q2:
    • Health: GBP 1.40 billion, matching the estimate.
    • Hygiene: GBP 1.45 billion, slightly below the estimated GBP 1.47 billion.
    • Nutrition: GBP 575 million, higher than the estimated GBP 559.7 million.
  • Future Outlook:
    • The company expects FY adjusted operating profit to grow ahead of net revenue growth.
    • Revenue growth expected to accelerate in the second half.
    • Plans to increase the dividend and initiate a Β£1 billion share buyback over the next 12 months.
    • FY LFL revenue growth outlook revised due to temporary supply disruption from a July

A look at Reckitt Benckiser Group Smart Scores

FactorScoreMagnitude
Value2
Dividend4
Growth5
Resilience2
Momentum2
OVERALL SMART SCORE3.0

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Reckitt Benckiser Group PLC, a global manufacturer of household, toiletry, health, and food products, is poised for a promising long-term outlook. Known for its wide array of consumer goods, the company has received strong Smart Scores in key areas. With a high Growth score of 5, Reckitt Benckiser is expected to maintain robust expansion in the future, indicating potential for increasing market share and profitability.

Additionally, the company’s solid Dividend score of 4 highlights its commitment to rewarding shareholders and generating sustainable returns. Although Value, Resilience, and Momentum scores are not as high, the combination of growth and dividend strengths suggests a positive trajectory for Reckitt Benckiser Group PLC in the coming years.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Stora Enso OYJ (STERV) Earnings: 2Q Operating EBIT Exceeds Estimates, Continued Profit Improvement Expected

By | Earnings Alerts
  • Stora Enso’s operating EBIT for Q2 2024 was EU161 million, significantly higher than last year’s EU37 million and above the estimate of EU156.1 million.
  • Sales for the quarter were EU2.30 billion, slightly below the estimated EU2.36 billion.
  • Adjusted earnings per share (EPS) were EU0.070, an improvement from a loss of EU0.27 per share last year, though below the estimate of EU0.11.
  • Operating EBIT margin stood at 7%.
  • Operating EBITDA reached EU312 million, representing a 58% increase year-over-year, just shy of the estimate of EU315.3 million.
  • Operating EBITDA margin was 13.6%, up from 8.4% the previous year.
  • For the first half of 2024, profit improvement continues, with expectations for full-year adjusted EBIT being significantly higher compared to 2023.
  • Niclas Rosenlew has been appointed as the new group CFO, replacing Seppo Parvi.
  • Stora Enso anticipates a gradual market recovery in 2024, driven by profitability initiatives.
  • High wood costs are expected to continue affecting margins.
  • Market uncertainties such as high inflation, potential strikes, and demand and price fluctuations are projected to persist through the end of the year.
  • For Q3, the outlook for packaging materials is slightly positive, supported by strong order books and improving prices.
  • Demand for packaging solutions in Q3 is expected to remain stable, with typical seasonal variations.
  • Pulp demand in Europe and China is stable, with the European softwood pulp market balanced and no signs of improvement in China.
  • CEO Hans Sohlstrom reports that a EU120m profit improvement program is advancing successfully.
  • The divestment process for the Beihai operation in China is progressing, with a focus on obtaining the right value for the assets.
  • Stock ratings: 13 buys, 5 holds, and 4 sells.

A look at Stora Enso OYJ Smart Scores

FactorScoreMagnitude
Value5
Dividend2
Growth3
Resilience3
Momentum3
OVERALL SMART SCORE3.2

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Stora Enso OYJ, an integrated paper, packaging, and forest products company, maintains a solid long-term outlook based on its Smartkarma Smart Scores. With a top-ranking Value score, indicating strong fundamentals, the company is positioned well for sustainable growth and profitability. However, the lower Dividend score suggests that investors may not see significant returns in the form of dividends in the foreseeable future.

Although Stora Enso OYJ scores moderately for Growth, Resilience, and Momentum, showcasing steady expansion, stability, and market performance respectively, there is room for improvement to enhance these aspects further. Overall, with an established global presence in over 40 countries and a diverse range of products sold to various industries, Stora Enso OYJ presents a promising investment opportunity amid its mixed Smart Scores.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars